0 CHECKOUT

PRODUCT FILTERS

CATEGORIES

  • 10
  • 9
  • 6
  • 6
  • 2
  • 1
  • 1

PRICE

4
4
33
35

PUBLISHED

0
7
22
35

PRODUCT TYPE

32
2
1

Search for: "Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors"

35 Products

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review

Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

Published:  June 2015
Price:  From

Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review

Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing...

Published:  September 2010
Price:  From

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Neurofibromatoses Type II - Pipeline Review, H1 2015

Neurofibromatoses Type II - Pipeline Review, H1 2015 Summary The‘Neurofibromatoses Type II - Pipeline Review, H1 2015’, provides an overview of the Neurofibromatoses Type II’s therapeutic pipeline. This...

Published:  May 2015
Price:  From

Neurofibromatoses Type II - Pipeline Review, H1 2014

Neurofibromatoses Type II - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H1 2014’, provides an overview of the Neurofibromatoses Type II’s...

Published:  February 2014
Price:  From

Brain Ischemia - Pipeline Review, H1 2014

Brain Ischemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report...

Published:  May 2014
Price:  From

Gaucher's Disease - Pipeline Review, H1 2015

Gaucher's Disease - Pipeline Review, H1 2015 Summary This, ‘Gaucher's Disease - Pipeline Review, H1 2015’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Brain Ischemia - Pipeline Review, H2 2014

Brain Ischemia - Pipeline Review, H2 2014 Summary This, ‘Brain Ischemia - Pipeline Review, H2 2014’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

Published:  November 2014
Price:  From

Brain Ischemia - Pipeline Review, H1 2015

Brain Ischemia - Pipeline Review, H1 2015 Summary This, ‘Brain Ischemia - Pipeline Review, H1 2015’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

Published:  April 2015
Price:  From

Gaucher's Disease - Pipeline Review, H2 2014

Gaucher's Disease - Pipeline Review, H2 2014 Summary This, ‘Gaucher's Disease - Pipeline Review, H2 2014’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

Published:  November 2014
Price:  From

Myocardial Ischemia - Pipeline Review, H1 2015

Myocardial Ischemia - Pipeline Review, H1 2015 Summary This, ‘Myocardial Ischemia - Pipeline Review, H1 2015’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

Published:  February 2015
Price:  From

Myocardial Ischemia - Pipeline Review, H2 2014

Myocardial Ischemia - Pipeline Review, H2 2014 Summary This, ‘Myocardial Ischemia - Pipeline Review, H2 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

Published:  October 2014
Price:  From

Neurofibromatoses Type II - Pipeline Review, H2 2014

Neurofibromatoses Type II - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H2 2014’, provides an overview of the Neurofibromatoses Type II’s...

Published:  July 2014
Price:  From

Competitor Analysis: Enzyme Replacement Therapies

The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies...

Published:  January 2013
Price:  From

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2014
Price:  From

Septic Shock - Pipeline Review, H1 2015

Septic Shock - Pipeline Review, H1 2015 Summary This, ‘Septic Shock - Pipeline Review, H1 2015’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

Published:  April 2015
Price:  From

Septic Shock - Pipeline Review, H2 2014

Septic Shock - Pipeline Review, H2 2014 Summary This, ‘Septic Shock - Pipeline Review, H2 2014’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2014
Price:  From

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015 Summary This, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides...

Published:  June 2015
Price:  From

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

Published:  October 2014
Price:  From

Ischemia - Pipeline Review, H1 2015

Ischemia - Pipeline Review, H1 2015 Summary This, ‘Ischemia - Pipeline Review, H1 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • Innocent Drinks Ltd.
  • Groupe Danone
  • Cisco Systems, Inc.
  • The World Bank Group
  • Swarovski AG
  • Owens Corning Corporation
  • Swiss Reinsurance Company Ltd.